In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Medtronic acquires Ardian for $800mm in cash, plus earn-outs

Executive Summary

Medtronic Inc. has agreed to buy the remaining 89% of closely held Ardian Inc. (catheter-based treatment of drug-resistant hypertension) that it does not already own for $800mm in cash. Shareholders may also receive earn-outs equal to the annual revenue growth through Medtronic's FYE 2015 (estimated at $500mm).
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Partial Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register